BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35930094)

  • 1. Aging compromises oligodendrocyte precursor cell maturation and efficient remyelination in the monkey brain.
    Dimovasili C; Fair AE; Garza IR; Batterman KV; Mortazavi F; Moore TL; Rosene DL
    Geroscience; 2023 Feb; 45(1):249-264. PubMed ID: 35930094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD.
    Jiang G; Ayaki T; Maki T; Yasuda K; Yoshii D; Kaji S; Takahashi R
    Neurosci Lett; 2023 Aug; 812():137405. PubMed ID: 37479175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
    Liu L; Du X; Yang Q; Li M; Ran Q; Liu Q; Yang L; Sun L; Guo Y; Li Y; Chen Y; Zhu X; Li Q
    Phytomedicine; 2022 Nov; 106():154309. PubMed ID: 35994846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
    Santiago González DA; Cheli VT; Zamora NN; Lama TN; Spreuer V; Murphy GG; Paez PM
    J Neurosci; 2017 Oct; 37(42):10038-10051. PubMed ID: 28899915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Postnatal Myelination in a Conditional Knockout Mouse for the Ferritin Heavy Chain in Oligodendroglial Cells.
    Wan R; Cheli VT; Santiago-González DA; Rosenblum SL; Wan Q; Paez PM
    J Neurosci; 2020 Sep; 40(40):7609-7624. PubMed ID: 32868463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
    Gorter RP; Baron W
    Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in oligodendrocyte development and remyelination.
    Ngo C; Kothary R
    J Neurochem; 2022 Aug; 162(4):310-321. PubMed ID: 35536759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
    Skaper SD
    Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
    Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
    J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury.
    Duncan GJ; Manesh SB; Hilton BJ; Assinck P; Plemel JR; Tetzlaff W
    Glia; 2020 Feb; 68(2):227-245. PubMed ID: 31433109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
    Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
    Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendrocyte progenitor cell-specific delivery of lipid nanoparticles loaded with Olig2 synthetically modified messenger RNA for ischemic stroke therapy.
    Xu J; Wang R; Luo W; Mao X; Gao H; Feng X; Chen G; Yang Z; Deng W; Nie Y
    Acta Biomater; 2024 Jan; 174():297-313. PubMed ID: 38096960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of astrocytes hinders parenchymal oligodendrocyte precursor cells from reaching a myelinating state in osmolyte-induced demyelination.
    Lohrberg M; Winkler A; Franz J; van der Meer F; Ruhwedel T; Sirmpilatze N; Dadarwal R; Handwerker R; Esser D; Wiegand K; Hagel C; Gocht A; König FB; Boretius S; Möbius W; Stadelmann C; Barrantes-Freer A
    Acta Neuropathol Commun; 2020 Dec; 8(1):224. PubMed ID: 33357244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Extracellular Matrix Proteins Tenascin-C and Tenascin-R Retard Oligodendrocyte Precursor Maturation and Myelin Regeneration in a Cuprizone-Induced Long-Term Demyelination Animal Model.
    Bauch J; Faissner A
    Cells; 2022 May; 11(11):. PubMed ID: 35681468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Tepavčević V; Lubetzki C
    Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.
    Su W; Matsumoto S; Banine F; Srivastava T; Dean J; Foster S; Pham P; Hammond B; Peters A; Girish KS; Rangappa KS; Basappa ; Jose J; Hennebold JD; Murphy MJ; Bennett-Toomey J; Back SA; Sherman LS
    Glia; 2020 Feb; 68(2):263-279. PubMed ID: 31490574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
    Plemel JR; Manesh SB; Sparling JS; Tetzlaff W
    Glia; 2013 Sep; 61(9):1471-87. PubMed ID: 23839973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Divalent Metal Transporter 1 (DMT1) Is Required for Iron Uptake and Normal Development of Oligodendrocyte Progenitor Cells.
    Cheli VT; Santiago González DA; Marziali LN; Zamora NN; Guitart ME; Spreuer V; Pasquini JM; Paez PM
    J Neurosci; 2018 Oct; 38(43):9142-9159. PubMed ID: 30190412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.